Cargando…

Arginase II: Atherogenesis Beyond Enzyme Activity

Detalles Bibliográficos
Autores principales:	Pandey, Deepesh, Romer, Lewis, Berkowitz, Dan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828780/ https://www.ncbi.nlm.nih.gov/pubmed/23938287 http://dx.doi.org/10.1161/JAHA.113.000392

Ejemplares similares

Endothelial arginase II and atherosclerosis
por: Ryoo, Sungwoo, et al.
Publicado: (2011)

Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis
por: Ming, Xiu‐Fen, et al.
Publicado: (2012)

Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice
por: Shin, Woosung, et al.
Publicado: (2012)

Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis in vivo: A Role for HDAC6 Neddylation
por: Nomura, Yohei, et al.
Publicado: (2021)

Development of Novel Arginase Inhibitors for Therapy of Endothelial Dysfunction
por: Steppan, Jochen, et al.
Publicado: (2013)

Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis
por: Rasheed, Adil, et al.
Publicado: (2018)

Exosomes and Atherogenesis
por: Lin, Bingbing, et al.
Publicado: (2021)

L-citrulline increases arginase II protein levels and arginase activity in hypoxic piglet pulmonary artery endothelial cells
por: Douglass, Matthew S., et al.
Publicado: (2021)

Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974)

Platelets in Inflammation and Atherogenesis
por: Nording, Henry M., et al.
Publicado: (2015)

Roles of Macrophages in Atherogenesis
por: Farahi, Lia, et al.
Publicado: (2021)

Arginase-II Deficiency Extends Lifespan in Mice
por: Xiong, Yuyan, et al.
Publicado: (2017)

Critical role for arginase II in osteoarthritis pathogenesis
por: Choi, Wan-Su, et al.
Publicado: (2019)

KCl-Dependent Release of Mitochondrial Membrane-Bound Arginase Appears to Be a Novel Variant of Arginase-II
por: Suman, Mishra, et al.
Publicado: (2016)

Commentary on “Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys”
por: Lim, Han Hyuk
Publicado: (2022)

Arginase II inhibitory activity of flavonoid compounds from Scutellaria indica
por: Kim, Sang Won, et al.
Publicado: (2013)

Role of pulmonary epithelial arginase‐II in activation of fibroblasts and lung inflammaging
por: Zhu, Cui, et al.
Publicado: (2023)

Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011)

The Importance of the Plasma Membrane in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2022)

Telomere Length: Implications for Atherogenesis
por: Yin, Hao, et al.
Publicado: (2023)

Role of tubular epithelial arginase-II in renal inflammaging
por: Huang, Ji, et al.
Publicado: (2021)

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function
por: Alzayadneh, Ebaa M., et al.
Publicado: (2023)

Role of Telomeres Shortening in Atherogenesis: An Overview
por: Yegorov, Yegor E., et al.
Publicado: (2021)

Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice.
por: Simeonova, Petia P, et al.
Publicado: (2003)

Role of Arginase-II in Podocyte Injury under Hypoxic Conditions
por: Ren, Zhilong, et al.
Publicado: (2022)

Infectious Agents Are Not Necessary for Murine Atherogenesis
por: Wright, Samuel D., et al.
Publicado: (2000)

The Dynamics of Oxidized LDL during Atherogenesis
por: Itabe, Hiroyuki, et al.
Publicado: (2011)

Notable epigenetic role of hyperhomocysteinemia in atherogenesis
por: Zhou, Shuyu, et al.
Publicado: (2014)

Intestinal Immunity and Gut Microbiota in Atherogenesis
por: Yamashita, Tomoya
Publicado: (2017)

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020)

Participation of Krüppel-like Factors in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2023)

Intracellular Delivery of β-Galactosidase Enzyme Using Arginase-Responsive Dextran Sulfate/Poly-l-arginine Capsule for Lysosomal Storage Disorder
por: Gupta, Meenakshi, et al.
Publicado: (2017)

Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance
por: Tommasi, S., et al.
Publicado: (2018)

An Intriguing and Important Concept Relevant to Oxidized Low-Density Lipoprotein and Atherogenesis is Still Problematic for its Contribution to the Better Understanding of Clinical Atherosclerosis
por: Yoshida, Hiroshi
Publicado: (2018)

Arginase and pulmonary diseases
por: Maarsingh, Harm, et al.
Publicado: (2008)

Natural Products: Therapeutic Properties and Beyond II
por: Duarte, Ana Paula, et al.
Publicado: (2022)

Arginase-II negatively regulates renal aquaporin-2 and water reabsorption
por: Huang, Ji, et al.
Publicado: (2018)

A synthetic peptide as an allosteric inhibitor of human arginase I and II
por: Gao, Kai, et al.
Publicado: (2021)

Arginase II activity regulates cytosolic Ca(2+) level in a p32-dependent manner that contributes to Ca(2+)-dependent vasoconstriction in native low-density lipoprotein-stimulated vascular smooth muscle cells
por: Koo, Bon-hyeock, et al.
Publicado: (2019)

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vt62tdtt5bk2amdjmmn6h0tgbo